MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Progressive supranuclear palsy(PSP)"

  • 2026 International Congress

    Phenotypic Evolution from Nonfluent PPA to PSP

    S. Park (Sejong-si, Republic of Korea)

    Objective: Progressive Supranuclear Palsy (PSP) and Nonfluent Primary Progressive Aphasia (nfvPPA) are clinicopathological entities within the 4-repeat tauopathy (4R tauopathy) spectrum. Increasing evidence suggests that…
  • 2026 International Congress

    MobilityAPP: A randomized-controlled trial evaluating 
gait-focused physiotherapy in Parkinson’s disease and 
atypical parkinsonian syndromes

    V. Sidoroff, C. Raccagni, H. Moradi, G. Prigent, F. Jagusch, I. Teckenburg, M. Giraitis, E. Schoenfeldt Reichmann, J. Ndayisaba, G. Göbel, K. Seppi, F. Krismer, D. Benninger, J. Winkler, B. Eskofier, J. Klucken, K. Aminian, A. Ionescu, S. Sapienza, H. Gaßner (Innsbruck, Austria)

    Objective: Effect on gait and balance of gait-focused physiotherapy compared to standard-of-care physiotherapy in patients with MSA, PSP and PD. Background: Physiotherapy is a crucial element…
  • 2026 International Congress

    Early Overlap of Corticobasal Syndrome and Richardson Syndrome in Corticobasal Degeneration: Evidence from 252 Autopsy-Confirmed Cases

    D. Ono, H. Sekiya, D. Dickson (Tokyo, Japan)

    Objective: This study aimed to identify early clinical phenotypes of corticobasal degeneration (CBD) using unsupervised analysis of a large clinicopathologic dataset. Background: Early diagnosis of…
  • 2026 International Congress

    QSM-Based Substantia Nigra Volumetry Improves Differentiation of Progressive Supranuclear Palsy from Parkinson’s Disease and Multiple System Atrophy

    S. Chung, S. Jo, H. Candan, M. Choi, G. Lee, E. Lee, H. Cho (Seoul, Republic of Korea)

    Objective: To evaluate whether quantitative susceptibility mapping (QSM)-based substantia nigra (SN) volumetry improves differentiation of progressive supranuclear palsy (PSP) from Parkinson’s disease (PD) and multiple…
  • 2026 International Congress

    Sex comparisons for co-pathologies and clinical phenotypes in autopsy-confirmed four-repeat tauopathies

    E. Bayram, D. Carter, S. Aslam, E. Forbes, S. Holden (Aurora, USA)

    Objective: To assess whether co-pathologies and clinical phenotypes in people with four-repeat tauopathies (progressive supranuclear palsy [PSP], corticobasal degeneration [CBD]) differ by sex. Background: PSP…
  • 2026 International Congress

    Utility of the Short Cognitive and Neuropsychiatric Assessment Scale (ShoCo) in a Multiethnic Asian Cohort of Patients with Progressive Supranuclear Palsy

    KKN. Chen, KH. Yap, TQ. Lim, ESY. Wong, JWY. Tee, AL. Lee, DWP. Lim, YX. Tee, YZ. Lim, JC. Fernandiz, YY. Beh, YW. Tay, TS. Toh, JP. Schee, WH. Tan, LC. Lit, E. Matar, AH. Tan, SY. Lim (Kuala Lumpur, Malaysia)

    Objective: To assess the clinical utility of the Short Cognitive and Neuropsychiatric Assessment (ShoCo) scale in a multi-ethnic Malaysian cohort of patients with progressive supranuclear…
  • 2026 International Congress

    Dysphagia and Oropharyngeal Freezing in Progressive Supranuclear Palsy

    P. Wang, Y. Xia, B. Wang, W. Luo, B. Xiong, W. Luo (Hangzhou, China)

    Objective: To investigate the characteristics and mechanism of dysphagia in patients with Progressive Supranuclear Palsy(PSP). Background: Up to 79% of patients with PSP suffer from…
  • 2026 International Congress

    Clinical Analysis of Progressive Supranuclear Palsy in Sri Lanka: Preliminary Results from a Cross-Sectional Collaborative Study with Global Parkinson’s Genetic Program (GP2)

    A. Pathirage, V. Vithudsha, P. Ruwanpathirana, B. Senanayake (colombo 08, Sri Lanka)

    Objective: Characterize the clinical phenotype of a Sri Lankan Progressive Supranuclear Palsy (PSP) cohort and identify correlations between severity  with cognitive impairment and functional status.…
  • 2026 International Congress

    Remotely Administered Reaction Time Correlates in Progressive Supranuclear Palsy

    T. Siejka, K. Bertram, H. Butzkueven, D. Darby, A. Brodtmann (Melbourne, Australia)

    Objective: To evaluate the cross-sectional associations of remotely administered reaction time (RT) in PSP. Background: PSP causes cognitive dysfunction, with severe deficits in psychomotor speed,…
  • 2026 International Congress

    Data-driven operational definition of square-wave jerks to optimize diagnostic discrimination of progressive supranuclear palsy

    D. Nguyen (Brisbane, Australia)

    Objective: To use a data-driven approach to create an optimal SWJ definition and to assess its diagnostic utility in PSP. Background: The Movement Disorder Society…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 49
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley